Evidence map›Paper›PMID 41173009›Full record

ArticleStem cell reports2025

Activation of canonical Wnt signaling is required for efficient direct reprogramming into human hepatic progenitor cells.

Shizuka Miura, Kenichi Horisawa, Hiroki Inada, Yoshiaki Sakaguchi, Masayoshi Yorino, Atsushi Suzuki

Abstract read
In one paragraph

Article in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shizuka MiuraDivision of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Kenichi HorisawaDivision of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Hiroki InadaDivision of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Yoshiaki SakaguchiDivision of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Masayoshi YorinoDivision of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Atsushi SuzukiDivision of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan. Electronic address: suzukicks@bioreg.kyushu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct reprogramming is a technique for elucidating the mechanisms that control cell-fate decisions and holds promise as a therapeutic strategy. We previously showed that a specific combination of three transcription factors (FOXA3, HNF1A, and HNF6) can induce direct reprogramming of human umbilical vein endothelial cells (HUVECs) into human induced hepatic progenitor cells (hiHepPCs). However, low reprogramming efficiency limits their application in research and therapy. Here, we show that activation of the canonical Wnt signaling pathway increases the reprogramming efficiency of HUVECs to hiHepPCs by rapidly inducing chromatin remodeling and gene expression changes in the transduced HUVECs. Moreover, endogenous Wnt activation, mainly mediated by WNT2B, is required for the initiation of direct reprogramming from HUVECs to hiHepPCs. Wnt activation that allows rapid induction of hiHepPCs enables efficient production of a large amount of hiHepPCs, which is an advantage in research and clinical applications using hiHepPCs and their descendants.

Indexed as

Cellular ReprogrammingHepatocytesStem CellsWnt Signaling PathwayCell DifferentiationChromatin Assembly and DisassemblyHumansHuman Umbilical Vein Endothelial CellsLiverWnt ProteinsWnt Proteinsdirect reprogrammingliverprogenitor celltranscription factorWnt signaling pathway

Identifiers

PMID41173009
PMCPMC12790713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.